Resilience Care Targets U.S. Expansion in Digital Oncology With New Leadership and Advisory Board

According to a recent LinkedIn post from Resilience Care, the digital oncology company is preparing to expand its remote therapeutic monitoring offering into the U.S. market. The post indicates that its solution is already implemented in more than 200 cancer centers globally and has supported over 35,000 patients along their care pathways.

The company’s LinkedIn post highlights the appointment of Greg Orr as General Manager U.S., noting his prior roles as COO of Jasper Health and VP of Digital Health at Walgreens. This leadership hire suggests a strategy focused on scaling operations and commercial adoption in U.S. oncology and digital health networks.

As shared in the post, Resilience Care also points to the formation of an advisory board comprising digital health and oncology specialists, including Eddie Martucci, Jill DeSimone, Anne Ireland, and Ethan Basch. Their backgrounds in biotech, oncology pharmaceuticals, nursing leadership, and patient-reported outcomes may help the company refine its clinical value proposition and navigate reimbursement and regulatory pathways.

For investors, the described U.S. expansion could signal a shift from regional European deployment toward a larger addressable market in American oncology care. If the company successfully leverages its existing clinical footprint and advisory expertise, it may enhance its competitive position in digital oncology and potentially drive revenue growth tied to remote monitoring and outcomes-based care models.